Press Releases about Arrowhead Pharma
Arrowhead Announces JNJ-75220795 in Development for NASH
November 17, 2021
Via Business Wire
Arrowhead Presents New Clinical Data on ARO-APOC3 at AHA 2021
November 15, 2021
Via Business Wire
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Year End Results
November 01, 2021
Via Business Wire
Via Business Wire
Arrowhead Earns $10 Million Phase 1 Milestone Payment
September 28, 2021
Via Business Wire
Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study
July 02, 2021
Via Business Wire
Arrowhead Earns $10 Million Option Exercise Fee
May 18, 2021
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.